Skip to main content
SpringerLink
Log in

Protein drug oral delivery: The recent progress

  • Research Articles
  • Articles
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Rapid development in molecular biology and recent advancement in recombinant technology increase identification and commercialization of potential protein drugs. Traditional forms of administrations for the peptide and protein drugs often rely on their parenteral injection, since the bioavailability of these therapeutic agents is poor when administered nonparenterally. Tremendous efforts by numerous investigators in the world have been put to improve protein formulations and as a result, a few successful formulations have been developed including sustained-release human growth hormone. For a promising protein delivery technology, efficacy and safety are the first requirement to meet. However, these systems still require periodic injection and increase the incidence of patient compliance. The development of an oral dosage form that improves the absorption of peptide and especially protein drugs is the most desirable formulation but one of the greatest challenges in the pharmaceutical field. The major barriers to developing oral formulations for peptides and proteins are metabolic enzymes and impermeable mucosal tissues in the intestine. Furthermore, chemical and conformational instability of protein drugs is not a small issue in protein pharmaceuticals. Conventional pharmaceutical approaches to address these barriers, which have been successful with traditional organic drug molecules, have not been effective for peptide and protein formulations. It is likely that effective oral formulations for peptides and proteins will remain highly compound specific. A number of innovative oral drug delivery approaches have been recently developed, including the drug entrapment within small vesicles or their passage through the intestinal paracellular pathway. This review provides a summary of the novel approaches currently in progress in the protein oral delivery followed by factors affecting protein oral absorption.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allémann, E., Gurney, R., and Doelker, E., Drug loaded nanopaticles-preparation methods and drug targeting issues.Eur. J. Pharm. Biopharm., 39, 173–191 (1993).

    Google Scholar 

  • Allen, A., Cuncliffe, W. J., Peerson, J. P., Sellers, L. A., and Ward, R., Studies on gastrointestinal mucus.Scan. J. Gastroenterol., 19 (suppl), 101–113 (1984).

    Google Scholar 

  • Alur, H., Beal, J.D., Pather, S. I., Mitra, A. K., and Johnston, T. P., Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets.J. Pharm. Sci., 88, 1313–1319 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Anderson, P. M., Hanson, D. C., Hasz, D. E., Halet, M. R., Blazer, B. R., and Ochoa, A. C., Cytokines in liposomes: preliminary studies with IL-1, IL-2, IL-6, GM-CSF and Interferon-gamma.Cytokine, 6, 92–101, (1994).

    Article  PubMed  CAS  Google Scholar 

  • Arimori, K. and Nakano, M., Drug exsorption from blood into the gastrointestinal tract.Pharm. Res., 15, 371–376 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Babiuk, S., Baca-Estrada, M., Babiuk, L. A., Ewen, C., and Foldvari, M., Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery.J. Control Release., 66, 199–214 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Bai, J. P., Chang, L. L., and Guo, J. H., Targeting of peptide and protein drugs to specific sites in the oral route.Crit. Rev. Ther. Drug Carrier Syst., 12, 339–371 (1995).

    PubMed  CAS  Google Scholar 

  • Baluom, M., Friedman, D. I., and Rubinstein, A., Absorption enhancement of calcitonin in the rat intestine by carbopolcontaining submicron emulsions.Int. J. Pharm., 154, 235–243 (1997).

    Article  CAS  Google Scholar 

  • Bell, D. S. and Ovalle, F., Use of soy protein supplement and resultant need for increased dose of levothyroxine.Endocr. Pract, 7, 193–194 (2001).

    PubMed  CAS  Google Scholar 

  • Beierle, I., Meibohm, B., and Derendorf, H., Gender differences in pharmacokinetics and pharmacodynamics.Int. J. Clin. Pharmacol. Then, 37, 529- (1999).

    CAS  Google Scholar 

  • Bernkop-Schnurch, A., Chitosan and its derivatives: potential excipients for peroral peptide delivery systems.Int. J. Pharm., 194, 1–13 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Bernkop-Schnurch, A., Schwarz, G. H., and Kratzel, M., Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides.J. Cont. Res., 47, 113–121, (1997a).

    Article  Google Scholar 

  • Bernkop-Schnurch, A., Bratengeyer, I., and Valenta, C., Development and in vitro evaluation of a drug delivery system protecting from trypsinic degradation.Int. J. Pharm., 157, 17–25 (1997b).

    Article  Google Scholar 

  • Bickel, U., Yoshikawa, T., and Pardridge, W. M., Delivery of peptides and proteins through the blood-brain barrier.Adv. Drug Deliv. Rev., 46, 247–279 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Burke, C. J., Hsu, T. A., and Volkin, D. B., Formulation, stability, and delivery of live attenuated vaccines for human use.Crit. Rev. Ther. Drug Carrier Syst., 16, 1–83 (1999).

    PubMed  CAS  Google Scholar 

  • Carreno-Gomez, B., Woodley, J. F., and Florence, A. T., Studies on the uptake of tomato lectin nanoparticles in everted gut sacs.Int. J. Pharm., 183, 7–11 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Cleland, J. L., Daugherty, A., and Mrsny, R., Emerging protein delivery methods.Curr. Opin Biotechnol., 12, 212–219 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Corbett, J., and Ross, K., Neoral: the new cyclosporine.ANNA. J., 25, 71–72 (1998).

    PubMed  CAS  Google Scholar 

  • Cornell, R. and Padykula, H. A., A cytological study of intestinal absorption in the suckling rat.Am. J. Anal., 125, 291–316 (1969).

    Article  CAS  Google Scholar 

  • DeVane, C. L. and Gill, H. S., Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.J. Clin. Psychiatry., 58, 7–14 (1997).

    PubMed  CAS  Google Scholar 

  • DiBiase, M. D., and Morrel, E. M., Oral delivery of microencapsulated proteins.Pharm. Biotechnol., 10, 255–288 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., and Tice, T. R., Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microsphere target the Peyers patches.J. Control. Rel., 11, 205–214 (1990).

    Article  CAS  Google Scholar 

  • Fasano, A., Novel approaches for oral delivery of macromolecules.J. Pharm. Sci., 87, 1351–1356 (1998a).

    Article  PubMed  CAS  Google Scholar 

  • Fasano, A., Innovative strategies for the oral delivery of drugs and peptides.Trends Biotechnol., 16, 152–157 (1998b).

    Article  PubMed  CAS  Google Scholar 

  • Fasano, A., Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases.Mol. Genet. Metab., 64, 12–18 (1998c).

    Article  PubMed  CAS  Google Scholar 

  • Fix, J. A., Oral controlled release technology for peptides: status and future prospects.Pharm. Res., 13, 1760–1764 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., and Pastan, I., Expression of a multidrug-resistance gene in human tumors and tissues.Proc. Natl. Acad. Sci. USA, 84, 265–269 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Foradori, A., Mezzano, S., Videla, O., Pefaur, J., and Elberg, A., Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazole in stable adult kidney transplants.Transplant Proa, 30, 1685–1687 (1998).

    Article  CAS  Google Scholar 

  • Fricker, G. and Drewe, J., Current concepts in intestinal peptide absorption.J. Pept. Sci., 2, 195–211 (1996).

    PubMed  CAS  Google Scholar 

  • Fromm, M. F., P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.Int. J. Clin. Pharmacol. Ther., 38, 69–74 (2000).

    PubMed  CAS  Google Scholar 

  • Fuiji, S., Yakohama, T., Ikegaya, K., Sato, F., and Yohoo, N., Promoting effect of the new chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats and dogs.J. Control. Rel., 13, 213–223 (1991).

    Google Scholar 

  • Garrido, A. B. Jr., Freeman, H.J., and Kim, Y.S., Amino acid and peptide absorption in bypassed jejunum following jejunoileal bypass in rats.Dig. Di. Sci., 26, 107–112, (1981).

    Article  CAS  Google Scholar 

  • Gonnella, P. A., Siminoski, K., Murphy, R. A., and Neutra, M. R., Transepithelial transport of epidermal growth factor by absorptive cells of suckling rat ileum.J. Clin. Invst., 80, 22–32 (1987).

    Article  CAS  Google Scholar 

  • Gonnella, P. A. and Neutra, M. R., Membrane-bound and fluidphase macromolecules enter separate prelysosomal compartments in absorptive cells of suckling rat ileum.J. Cell Biol., 99, 909–917 (1984).

    Article  PubMed  CAS  Google Scholar 

  • Gregg, C. R., Drug interactions and anti-infective therapies.Am. J. Med., 106, 227–237 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Grevel, J., Nuesch, E., Abisch, E., and Kutz, K., Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects.Eur. J. Clin. Pharmacol., 31, 211–216 (1986).

    Article  PubMed  CAS  Google Scholar 

  • Gutniak, M. K., Larsson, H., Heiber, S. J., Juneskans, O. T., Hoist, J. J., and Ahren, B. Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet.Diabetes Care, 19, 843–848 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Habberfield, A., Jensen-Pippo, K., Ralph, L., Westwood, S., and Russel-Jones, G. J., Vitamin Bb12-mediated uptake of recombinant therapeutic proteins from the gut.Int. J. Pharm., 145, 1–8 (1996).

    Article  CAS  Google Scholar 

  • Harris, R. Z., Benet, L. Z., and Schwartz, J. B., Gender effects in pharmacokinetics and pharmacodynamics.Drugs, 50, 222–239 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Jani, P., Halbert, G. W., Langridge, J., and Florence, T., The uptake and translocation of latex nanospheres and microspheres after oral administration to rats.J. Pharm. Pharmacol., 41, 809–812 (1989).

    PubMed  CAS  Google Scholar 

  • Jung, T., Kamm, W., Breitenbach, A., Kaiserling, E., Xiao, J. X., and Kissel, T., Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake.Eur. J. Pharm. Biopharm., 50, 147–160 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Kararli, T. T., Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals.Biopharm. Drug Dispos., 16, 351–380 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Keljo, D. J., Hamilton, J. R., Quantitative determination of macromolecular transport rate across intestinal Peyers patches.Am. J. Physiol., 244, G637-G644 (1983).

    PubMed  CAS  Google Scholar 

  • Kennedy, A. R., The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.Am. J. Clin. Nutr., 68, 1406S-1412S (1998).

    PubMed  CAS  Google Scholar 

  • Kohler, E., Duberow, D. M., Drew, J., Ribes, G., Loubatieres, M. M. M., Mazer, N., Gyr, K., and Berlinger, C., Absorption of an aqueous solution of a new synthetic somatostatin analogue administered to man by gavage.Eur. J. Clin. Pharmacol., 33, 167–171 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Kompella, U. B. and Lee, V. H., Delivery systems for penetration enhancement of peptide and protein drugs: design considerations.Adv. Drug Deliv. Rev., 46, 211–245 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Kratzel, M., Heissbock, R., and Bernkop-Schnurch, A., Auxiliary agents for the peroral administration of peptide and protein drugs: synthesis and evaluation of novel pepstatin analogues.J. Med. Chem., 41, 2339–2344 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Kreuter, J., Peroral administration of nanoparticles.Adv. Drug Deliv. Rev., 7, 71–86 (1991).

    Article  CAS  Google Scholar 

  • Kurosaki, Y. and Kimura, T., Regional variation in oral mucosal drug permeability.Crit. Rev. Ther. Drug Carrier Syst., 17, 467–508 (2000).

    PubMed  CAS  Google Scholar 

  • Larkins, B. A., Pedersen, K., Marks, M.D., and Wilson, D. R., The zein proteins of maize endosperm.Trends Biochem. Sci., July, 306–308 (1984).

    Article  Google Scholar 

  • Lasic, D.D. and Papahadjopoulos, D., Liposomes revisited.Science, 267, 1275–1276 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Lee, V. H. L., Protease inhibitors and penetration enhancers as approaches to modify peptide absorption.J. Control. Rel., 13, 213–223 (1991).

    Article  Google Scholar 

  • Lee, V. H. L., Membrane transporters.Eur. Pharm. Sci., 11, S41–50 (2000).

    Article  CAS  Google Scholar 

  • Lee, H.J. and Amidon, G. L., The effect of enzyme inhibitor and absorption site following [D-ala2, D-leu5]enkephalin oral administration in rats.Biopharm. Drug Dispos. 23, 131–141 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Lee, H. J. and Lee, M. G. Controlling absorption site, metabolism, and membrane permeability in the intestine to develop strategies for protein drug oral delivery. Abstract submitted for the 16th annual meeting of the AAPS to be held in Toronto, Canada in November, 2002.

  • Lee, H.J., Riley, G., Johnson, O., Cleland, J. L., Kim, N., Charnis, M., Baily, L., Duenas, E., Shahzamani, A., Marian, M., Jones, A.J.S., and Putney, S. D. In vivo characterization of sustained-release formulations of human growth hormone,J. Pharmacol. Exp. Then., 281, 1431–1439 (1997).

    CAS  Google Scholar 

  • Lehr, C. M., Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.Crit. Rev. Ther. Drug Carrier Syst., 11, 119–160 (1994).

    PubMed  CAS  Google Scholar 

  • Lehr, C. M., Bouwstra, J. A., Tukker, J. J., and Junginger, H. E., Intestinal transit of bioadhesive microspheres in an in situ loop in the rat. A comparative study with polymers and blends based on poly(acrylic acid).J. Control. Rel., 13, 51–62 (1990).

    Article  CAS  Google Scholar 

  • Leone-Bay, A., Ho, K.K., Agarwal, R., Baughman, R. A., Chaudhary, K., De Morin, F., Genoble, L., Mclnnes, C., Lercara, C., Milstein, S., OToole, D., Sarubbi, D., Variano, B., and Paton, D. R. 4-[4-(2-hydroxybenzoyl)aminophenyl]- butyric acid as a novel oral delivery agent for recombinant human growth hormone.J. Med. Chem., 39, 2571–2578 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Leone-Bay, A., Paton, D. R., and Weidner, J. J., The development of delivery agents that facilitate the oral absortion of macromolecular drugs.Med. Res. Rev., 20, 169–186 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Lipka, E., Crison, J., and Amidon, G. L., Transmembrane transport of peptide type compounds: prospects for oral delivery.J. Control. Rel., 39, 121–129 (1996).

    Article  CAS  Google Scholar 

  • Lundin, S. and Vilhardt, H., Absorption of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in rabbits.tActa Endocrinol., 112, 457–460 (1986).

    CAS  Google Scholar 

  • Macfarlane, G. T., Cummings, J. H., Macfarlane, S., and Gibson, G. R., Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3- stage continuous culture system.J. App. Bad., 67, 520–527 (1989).

    CAS  Google Scholar 

  • Mannino, R. J. and Gould-Fogerite, S., Lipid matrix-based vaccines for mucosal and systemic immunization.Pharm. Biotechnol., 6, 363–387 (1995).

    PubMed  CAS  Google Scholar 

  • Merkle, H. P., New aspects of pharmaceutical dosage forms for controlled drug delivery of peptide and proteins.Eur. J. Pharm. Sci., 2, 19–21 (1994).

    Article  CAS  Google Scholar 

  • Mestecky, J., Michalek, S. M., Moldoveanu, Z., and Russell, M. W., Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.Behring. Inst. Mitt., 98, 33–43 (1997).

    PubMed  CAS  Google Scholar 

  • Miller, D. B., and Spence, J. D., Clinical pharmacokinetics of fibric acid derivatives (fibrates).Clin. Pharmacokinet., 34, 155–162 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Nagai, T., Drug delivery systems by controlled release.Yakugaku Zasshi, 108, 613–624 (1988).

    PubMed  CAS  Google Scholar 

  • Nakane, S., Kakumoto, M., Yukimatsu, K. and Chien, Y. W., Oramucosal delivery of LHRH: pharmacokinetic studies of controlled and enhanced transmucosal permeation.Pharm. Dev. Technol., 1, 251–259 (1996).

    Article  PubMed  CAS  Google Scholar 

  • New, R. R. C., Guard, P. W., Littlewood, G. M., Sandbank, B. M., and Flynn, M. J., Administration of calcitonin to humans: comparison of intra-nasal and oral routes. Third European Symposium on Controlled Release Drug Delivery, Noordwijk aan Zee, The Netherlands, April 6–8 (1994).

  • Oh, D. M., Han, H. K., and Amidon, G. L., Drug transport and targeting. Intestinal transport.Pharm. Biotechnol., 12, 59–88 (1999).

    Article  PubMed  CAS  Google Scholar 

  • OHagan, D.T., Microparticles as oral vaccines. In Novel delivery systems for oral vaccines, (D. T OHagan, ed.), CRC Press, Boca Raton, FL; CRC Press, pp. 188–197, 1994.

    Google Scholar 

  • Owen, R. L., and Bhalla, D. K., Cytochemical analysis of alkaline phosphatase and esterase activities and of lectin-binding and anionic sites in rat and mouse Peyers patch M-cells.Am. J. Anal., 168, 199–212 (1983).

    Article  CAS  Google Scholar 

  • Park, K. and Robinson, J. R., Bioadhesive polymers as platforms for oral-controlled drug-delivery: method to study bioadhesion.Int. J. Pharm., 19, 107–127 (1984).

    Article  CAS  Google Scholar 

  • Paine, M. F., Khalight, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L, Perkins, J. D., Thummel, K. E. Characterization of intestinal and intraintestinal variations in human CYP3A-dependent metabolism.J. Pharmacol. Exp. Ther., 283, 1552–1562 (1997).

    PubMed  CAS  Google Scholar 

  • Picsitelli, S. C., Reiss, W. G., Figg, W. D., and Petros, W. P., Pharmacokinetics studies with recombination cytokines. Scinetific issues and practical considerations.Clin. Pharmacokinet., 32, 368–381 (1997).

    Article  Google Scholar 

  • Quintanar-Guerrero, D., Allémann, E., Fessi, H., and Doelker, E., Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers.Drug Dev. Ind. Pharm., 24, 1113–1128 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Ray, R., Novak, M., Duncan, J. D., Matsuoka, Y., and Compans, R. W., Microencapsulated human parainfluenza virus induces a protective immune response.J. Infect. Dis. 167, 752–755 (1993).

    PubMed  CAS  Google Scholar 

  • Rubinstein, A., Approaches and opportunities in colon-specific drug delivery.Crit. Rev. Ther. Drug Carrier Syst., 12, 101–149 (1995).

    PubMed  CAS  Google Scholar 

  • Russell-Jones, G. J., Use of vitamin B12 conjugates to deliver protein drugs by the oral route.Crit. Rev. Ther. Drug Carrier Syst., 15, 557–586 (1998).

    PubMed  CAS  Google Scholar 

  • Russell-Jones, G. J., Arthur, L., and Walker, H., Vitamin B12-mediated transport of nanoparticles across Caco-2 cells.Int. J. Pharm. 179, 247–255 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Saffran, M., Kumar, G.S., Savariar, C., Burnham, J. C., William, F., and Neckers, D. C., A new approach to the oral administration of insulin and other peptide drugs.Science. 233, 1081–1084 (1986).

    Article  PubMed  CAS  Google Scholar 

  • Sakuma, S., Hayashi, M., and Akashi, M., Design of nanoparticles composed of graft copolymers for oral peptide delivery.Adv. Drug Deliv. Rev., 47, 21–37 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Samanen, J., Wilson, G., Smith, P. L., Lee, C. P., Bondinell, W., Ku, T., Rhodes, G., and Nichols, A., Chemical approaches to improve the oral bioavailability of peptidergic molecules.J. Pharm. Pharmacol., 48, 119–135 (1996).

    PubMed  CAS  Google Scholar 

  • Schellens, J. H., Malingre, M. M., Kruijtzer, C. M., Bardelmeijer, H.A., Van Tellingen, O., Schinkel, A. H., and Beijnen, J. H., Modulation of oral bioavailability of anticancer drugs: from mouse to man.Eur. J. Pharm. Sci., 12, 103–110 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Scrips Report, Biopharmaceuticals: a new era of discovery in the biotechnology revolution. PJB Publications Ltd., Surray, UK, (2001)

  • Senel, S., Kremer, M., Nagy, K., and Squier, C., Delivery of bioactive peptides and proteins across oral (buccal) mucosa.Curr. Pharm. Biotechnol., 2, 175–186 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Spahn-Langguth, H., and Langguth, P., Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol.Eur. J. Pharm. Sci., 12, 361–367 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Stoll, B. R., Leipold, H. R., Milstein, S., and Edwards, D. A., A mechanistic analysis of carrier-mediated oral delivery of protein therapeutics.J. Control. Rel., 64, 217–228 (2000).

    Article  CAS  Google Scholar 

  • Su, S.-F., Amidon, G. L., and Lee, H. J., The intestinal metabolism and absorption of cholecystokinin analogs in rats.Biochem. Biophys. Res. Commun. 292, 632–638. (2002).

    Article  PubMed  CAS  Google Scholar 

  • Suzuki, H., and Sugiyama, Y., Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine.Eur. J. Pharm. Sci., 12, 3–12 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Takeuchi, H., Yamamoto, H., and Kawashima, Y., Mucoadhesive nanoparticulate systems for peptide drug delivery.Adv. Drug Deliv. Rev., 47, 39–54 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Tanaka, E., Gender-related differences in pharmacokinetics and their clinical significance.J. Ciln. Pharm. Ther., 24, 339–346 (1999).

    Article  CAS  Google Scholar 

  • Thurmann, P. A. and Hompesch, B. C., Influence of gender on the pharmacokinetics and pharmacodynamics of drugs.Int. J. Clin. Pharmacol. Ther., 36, 586–590 (1998).

    PubMed  CAS  Google Scholar 

  • Thomas, N. W., Jenkins, P. G., Howard, K. A., Smith, M. W., Lavelle, E. C., Holland, J., and Davis, S. S., Particle uptake and translocation across epithelial membranes.J. Anat., 189, 487–490 (1996).

    PubMed  Google Scholar 

  • Torres-Lugo, M. and Peppas, N. A., Transmucosal delivery systems for calcitonin: a review.Biomaterials, 21, 1191–1196 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Tsuji, A. and Tamai, I., Carrier-mediated intestinal transport of drugs.Pharm. Res., 13, 963–977 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Van Asperen, J., Van Tellingen, O., and Beijnen, J. H., The pharmacological role of P-glycoprotein in the intestinal epithelium.Pharmacol. Res., 37, 429–435 (1998).

    Article  PubMed  Google Scholar 

  • Verbeeck, C. K. and Horsmans, Y., Effect of hepatic insufficiency on pharmacokinetics and drug dosing.Pharm. World Sci., 20, 183–192 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Vaes, G., Digestive capacity of lysosomes, In Hers, H. G. and Van Hoof, F. (Eds.). Lysosomes and Storage Diseases, Academic Press, London, pp. 43–59, (1973).

    Google Scholar 

  • Vyas, S. P., Venugopalan, P., Sood, A., and Mysore, N., Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes.Pharmazie., 52, 339–345 (1997).

    PubMed  CAS  Google Scholar 

  • Wacher, V. J., Salphati, L., and Benet, L. Z., Active secretion and enterocytic drug metabolism barriers to drug.Adv. Drug Deliv. Rev., 46, 89–102 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Wacher, V. J., Silverman, J. A., Zhang, Y., and Benet, L. Z., Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. J.Pharm. Sci., 87, 1322–1330 (1998).

    Article  CAS  Google Scholar 

  • Walker, G. R, Langoth, N., and Bernkop-Schnurch, A., Peptidase activity on the surface of the porcine buccal mucosa.Int. J. Pharm., 21, 233, 141–147 (2002).

    Article  Google Scholar 

  • Wasan, K. M., Formulation and physiological and biopharmaceutical issues in the development of oral lipidbased drug delivery systems.Drug Dev. Ind. Pharm., 27, 267–276 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Watts, T. L., and Fasano, A., Modulation of intestinal permeability: a novel and innovative approach for the oral delivery of drugs, macromolecules and antigens.Biotechnol. Genet. Eng. Rev., 17, 433–453 (2000).

    PubMed  CAS  Google Scholar 

  • Woodley, J. F., Peptidase enzymes of G.I. tract; barriers to peptide delivery, but potential for controlled release.Proc. Int. Symp. Control Rel. Bioact. Mater., 19, 2–5, (1992).

    Google Scholar 

  • Woodley, J. F., Enzymatic barriers for Gl peptide and protein delivery.Crit. Rev. Ther. Drug Carrier Syst., 11, 61–95 (1994).

    PubMed  CAS  Google Scholar 

  • Yamamato, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M., and Muranishi, J., Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats.Pharm. Res., 11, 1496–1500 (1994).

    Article  Google Scholar 

  • Yang, C. Y., Dantzig, A. H., and Pidgeon, C., Intestinal peptide transport systems and oral drug availability.Pharm. Res., 16, 1331–1343 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Ye, Q., Asherman, J., Stevenson, M., Brownson, E., and Katre, N. V., DepoFoam™ technology: a vehicle for controlled delivery of protein and peptide drugs.J. Control. Rel., 64, 155–166 (2000).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy (Building 29) and Research Institute of Pharmaceutical Sciences, Seoul National University, San 56-1, Shinlim-Dong, 151-742, Kwanak-Gu, Seoul, Korea

    Hye J. Lee

Authors
  1. Hye J. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hye J. Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, H.J. Protein drug oral delivery: The recent progress. Arch Pharm Res 25, 572–584 (2002). https://doi.org/10.1007/BF02976925

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02976925

Key words

Search

Navigation